Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-1

Improvement in Cystoid Macular Edema Secondary to Systemic Bevacizumab in a Patient With Coats Plus Syndrome

Saima Khan, Cole A. Martin, Shannon Scarboro [...]

Journal of VitreoRetinal Diseases

Open access

Review article

First published 2025-04

Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy

Long-Bin Jeng, Horng-Ren Yang, Chiao-Fang Teng

Cancer Control

Open access

Case report

First published 2021

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Yukinobu Watanabe, Masahiro Ogawa, Yu Tamura [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2023

Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series

Takenori Ichimura, Daisuke Ichikura, Miwa Hinata [...]

Sage Open Medical Case Reports

Open access

Research article

First published 2024-08

Raltitrexed Chemotherapy Regimen Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer: A Prospective Multicenter Phase II Trial

Sheng Li, Xiaoyou Li, Qianni Zhu [...]

Cancer Control

Open access

Review article

First published 2021

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study

Jie Zhang, Di Wu, Ziran Zhang [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2020

Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study,a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC

Daniela Bianconi, Merima Herac, Florian Posch [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Effectiveness and Safety of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter,Retrospective Real-World Study in China

Minghua Shao, Binbin Tan, Chao Fan [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2023

Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab

Alessandro Passardi, Irene Azzali, Alessandro Bittoni [...]

Therapeutic Advances in Medical Oncology

Search results